D.A. DAVIDSON & CO. - KITE PHARMA INC ownership

KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of KITE PHARMA INC
ValueSharesWeighting
Q2 2017$119,000
+32.2%
1,1500.0%0.00%
+50.0%
Q1 2017$90,000
+50.0%
1,150
-14.8%
0.00%
+100.0%
Q4 2016$60,000
-1.6%
1,350
+22.7%
0.00%
-50.0%
Q3 2016$61,000
+10.9%
1,1000.0%0.00%0.0%
Q2 2016$55,000
+10.0%
1,1000.0%0.00%0.0%
Q1 2016$50,000
-25.4%
1,1000.0%0.00%0.0%
Q4 2015$67,000
+9.8%
1,1000.0%0.00%0.0%
Q3 2015$61,000
+1.7%
1,100
+10.0%
0.00%0.0%
Q2 2015$60,0001,0000.00%
Other shareholders
KITE PHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,358,084$185,086,00058.62%
BAINCO INTERNATIONAL INVESTORS 879,840$69,059,0009.77%
Coastal Bridge Advisors, LLC 235,140$18,456,0006.29%
MENORA MIVTACHIM HOLDINGS LTD. 1,433,899$112,547,0005.71%
NEXTHERA CAPITAL LP 105,000$8,241,0004.20%
ARK Investment Management 87,364$6,857,0001.98%
Casdin Capital, LLC 42,500$3,336,0001.97%
BB BIOTECH AG 740,000$58,083,0001.90%
FT Options LLC 81,700$1,287,0001.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 55,500$4,346,0001.66%
View complete list of KITE PHARMA INC shareholders